Toxicity of 8-methoxypsoralen, 5-methoxypsoralen, 3-carbethoxypsoralen, or 5-methylisopsoralen with ultraviolet radiation in the hairless (HRA/Skh) mouse
- PMID: 3590190
- DOI: 10.1016/0041-008x(87)90177-3
Toxicity of 8-methoxypsoralen, 5-methoxypsoralen, 3-carbethoxypsoralen, or 5-methylisopsoralen with ultraviolet radiation in the hairless (HRA/Skh) mouse
Abstract
An experimental design to simulate PUVA therapy (oral 8-methoxypsoralen followed by uv radiation) has been tested in a 13-week subchronic study to determine the relative toxicities of 8-methoxypsoralen (8-MOP), 5-methoxypsoralen (5-MOP), 5-methylisopsoralen (5-MIP), and 3-carbethoxypsoralen (3-CEP) in inbred hairless mice (HRA/Skh). Drug was administered by 1-hr pulse feedings three times a week after mice were fasted overnight; individually housed animals were then exposed to uv radiation (320-400 nm; less than 2% output less than 320 nm). 8-MOP or 5-MOP administered orally (at doses of approximately 240 or 480 mg/m2 body surface area per week) followed one-half hour later with uv radiation of 2 J/cm2 for 13 weeks were found to cause skin toxicity including inflammation, hyperplasia, ulceration, and cellular atypia. Dose-related toxicity was not seen in other organ systems. Corresponding levels of 5-MIP or 3-CEP with uv radiation did not produce skin toxicity. These studies show that the psoralens with two potential DNA-binding sites (8-MOP and 5-MOP) were more toxic than psoralens with only one photoreactive site (5-MIP and 3-CEP).
Similar articles
-
Ocular effects of treatment with various psoralen derivatives and ultraviolet-A (UVA) radiation in HRA/Skh hairless mice.Acta Ophthalmol (Copenh). 1986 Aug;64(4):471-8. doi: 10.1111/j.1755-3768.1986.tb06955.x. Acta Ophthalmol (Copenh). 1986. PMID: 3776510
-
Tumors of the skin in the HRA/Skh mouse after treatment with 8-methoxypsoralen and UVA radiation.Fundam Appl Toxicol. 1991 Jan;16(1):92-102. doi: 10.1016/0272-0590(91)90138-t. Fundam Appl Toxicol. 1991. PMID: 2019354
-
Effect on topical 5-methoxypsoralen on tumorigenesis induced in albino and pigmented hairless mouse skin by UV irradiation.J Photochem Photobiol B. 1990 May;5(3-4):343-57. doi: 10.1016/1011-1344(90)85050-7. J Photochem Photobiol B. 1990. PMID: 2115915
-
Photochemotherapy using pyridopsoralens.Biochimie. 1985 Mar-Apr;67(3-4):417-22. doi: 10.1016/s0300-9084(85)80090-0. Biochimie. 1985. PMID: 3899194 Review.
-
Photocarcinogenicity of psoralens used in PUVA treatment: present status in mouse and man.J Photochem Photobiol B. 1990 Jun;6(1-2):237-47. doi: 10.1016/1011-1344(90)85093-c. J Photochem Photobiol B. 1990. PMID: 2121937 Review.
Cited by
-
Coumarin derivatives as anticancer agents targeting PI3K-AKT-mTOR pathway: a comprehensive literature review.Med Oncol. 2025 Jun 30;42(8):301. doi: 10.1007/s12032-025-02844-9. Med Oncol. 2025. PMID: 40587024 Review.
-
DNA interstrand crosslink repair and cancer.Nat Rev Cancer. 2011 Jun 24;11(7):467-80. doi: 10.1038/nrc3088. Nat Rev Cancer. 2011. PMID: 21701511 Free PMC article. Review.
-
In vivo activation of human immunodeficiency virus type 1 long terminal repeat by UV type A (UV-A) light plus psoralen and UV-B light in the skin of transgenic mice.J Virol. 1991 Sep;65(9):5045-51. doi: 10.1128/JVI.65.9.5045-5051.1991. J Virol. 1991. PMID: 1908029 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources